Intravenous fluid (IVF) therapy is an integral component in the care of the acutely ill child. With advances in medical care and the ability to care for ever sicker children, both the need for IVF therapy and the complexity of prescribing those fluids have similarly increased. Although IVF therapy can be a lifesaving treatment that offers essential supportive care for a variety of diseases, it can also be associated with metabolic complications leading to morbidity and mortality, in particular hyponatremia. IVF therapy needs to be carefully prescribed and dose adjusted for each disease state in order to prevent or correct a disorder in serum sodium or volume status. This review will discuss how to adjust both the sodium composition and the rate of administration of IVFs in order to prevent a disorder in serum sodium or volume status in a variety of commonly encountered disease states in pediatrics.
Introduction
Intravenous fluid (IVF) therapy is an integral component in the care of the acutely ill child. With advances in medical care and the ability to care for ever sicker children, both the need for IVF therapy and the complexity of prescribing those fluids have similarly increased. Although IVF therapy can be a lifesaving treatment that offers essential supportive care for a variety of diseases, it can also be associated with metabolic complications leading to morbidity and mortality, in particular hyponatremia. IVF therapy needs to be carefully prescribed and dose adjusted for each disease state in order to prevent or correct a disorder in serum sodium or volume status. This review will discuss how to adjust both the sodium composition and the rate of administration of IVFs in order to prevent a disorder in serum sodium or volume status in a variety of commonly encountered disease states in pediatrics.
Dangers of hospital-acquired hyponatremia
Hyponatremia, serum sodium less than 135 mEq/l, is the most common electrolyte abnormality, affecting approximately 25% of hospitalized children (Table 1) [1 ,2,3, 4 ,5 ,6 ,7] . The majority of hyponatremia occurs in children receiving hypotonic fluids in the hospital setting and can therefore be viewed as an iatrogenic complication of inappropriate fluid therapy. The most serious complication of hospital-acquired hyponatremia is hyponatremic encephalopathy, for which children are at particularly high risk as they have a larger brain-tointracranial volume ratio than adults, which allows less room for brain expansion. We have documented over 60 reported cases from the past 20 years of death or permanent neurologic impairment resulting from acute hospital-acquired hyponatremia in children receiving hypotonic [8, 9 ], and we have warned against the administration of hypotonic fluids [10] [11] [12] [13] . These concerns have since drawn the attention of safety organizations worldwide. In 2007, the National Patient Safety Agency in the UK issued a warning about the use of hypotonic fluids [14] , which was followed by similar warnings from the Institute for Safe Medication Practices (ISMP) of both Canada (2008) [15] and the USA (2009) [16, 17 ]. These warnings were prompted by additional reports of death from hyponatremic encephalopathy in otherwise healthy children receiving hypotonic fluids.
The issue of preventing hospital-acquired hyponatremia has now achieved greater prominence as it has become increasingly clear in the adult population that any degree of hyponatremia can have dangerous consequences and is associated with increased morbidity and mortality [18 ] . It is now known that mild chronic hyponatremia (sodium <130 mEq/l) in adults can produce subtle neurological impairment affecting both gait and attention, similar to that of moderate alcohol intake [19] . This appears to explain why hyponatremia has been increasingly associated with falls and bone fractures in the elderly [19, 20] . There is additional evidence in both animals and humans that chronic hyponatremia contributes to osteopenia [21 ,22 ] . It is now well established in adults that hospital-associated hyponatremia is an independent risk factor for all-cause mortality [18 ] , with studies documenting an association in the ambulatory setting [23] and general medical wards [24] , as well as in patients with community acquired pneumonia [25] , congestive heart failure [26] , and end-stage liver disease [27] . Hyponatremia is also recognized as an independent predictor of increased medical costs in adults [28] . Although similar studies are lacking in pediatrics, it has been recently demonstrated in preterm neonates (<33 weeks gestation) that hyponatremia is the most predictive risk factor for poor neuromotor outcome [29 ,30] . In light of the accumulated evidence for the deleterious consequences of hyponatremia, strategies to prevent hyponatremia should be employed when prescribing IVFs.
Prevention of hospital-acquired hyponatremia
The historical approach to maintenance fluid therapy, laid out over 50 years ago, has been to administer IVFs at a rate and composition that approximates the daily urinary and insensible losses in an average child [31] . Maintenance fluids were prescribed at a rate of 1500 ml/m 2 /day (assigning 1 ml of water for each kcal utilized), with a sodium composition of IVF of 30 mEq/l, which is based on the average sodium content in low solute infant formula [31] [32] [33] [34] . Although this approach may be appropriate for a stable patient requiring long-term tube feeds or total parenteral nutrition, it does not answer the fluid needs of the acutely ill child. A variety of common disorders encountered in hospitalized children are associated with arginine vasopressin (AVP) excess, which places children at risk for the development of hyponatremia when hypotonic fluids are administered. Recent studies have revealed that the historic approach of prescribing hypotonic fluids in children results in an unacceptably high incidence of hyponatremia [3, 4 ,5 , , 7,35] . In 2003, we recommended that hypotonic fluids be avoided in patients at risk for hospital-acquired hyponatremia and that isotonic fluids be used for the prevention of hyponatremia in the high-risk patient [10] . Since that time, a number of recent prospective trials have demonstrated that 0.9% NaCl is a more suitable maintenance fluid, effectively preventing the development of hyponatremia [36 ,37 ,38,39 ,40 ]. Indications for 0.9% sodium chloride (154 mEq/l) in maintenance fluids
The administration of 0.9% NaCl is primarily indicated for disease states that are associated with AVP excess. As can be seen from Table 2 , these disorders encompass the vast majority of hospitalized children requiring maintenance parenteral fluids. For these conditions 0.9% NaCl would be administered in 5% dextrose in water at a rate of approximately 1500 ml/m 2 per day, after the commonly used Holliday and Segar formula [32] . There is little or no advantage to fluid restricting this group of patients to rates lower than this. Prospective studies which included a fluid restriction arm have found it either ineffective in preventing a fall in serum sodium or likely to lead to volume depletion [37 ,39 ,40 ,41] . It should be noted that even normal saline could result in a fall in serum sodium in a patient with a fixed inability to excrete free water and a urine osmolality exceeding 530 mOsm/kg H 2 O [42] . One exception where the use of 0.9% NaCl may be ineffective in adequately preventing hospitalacquired hyponatremia is in neurosurgical patients, where cerebral salt wasting can develop. Below is a discussion of the fluid management strategies of common childhood disorders associated with AVP excess, where hypotonic fluids should be avoided and 0.9% NaCl administered.
Hypovolemic states
Volume depletion (dehydration) is a frequent reason that children require IVFs in the acute care setting. Numerous conditions can lead to volume depletion, the most common being gastroenteritis. Volume depletion can be either isonatremic, hyponatremic, or hypernatremic. Regardless of the type, the volume deficit is primarily extracellular, and fluid resuscitation should be with an isotonic fluid. Children with moderate to severe volume depletion should receive rapid administration of isotonic fluids in doses ranging from 20 to 60 ml/kg in order to re-establish tissue and organ perfusion. Hypovolemia is a potent stimulus for vasopressin production, and the administration of hypotonic fluid will predictably result in hyponatremia from water retention [43] . Unfortunately, a common practice in pediatrics is to either treat volume depletion with hypotonic fluids, use hypotonic fluids following acute volume expansion, or increase the maintenance fluid rate 50-100% with a hypotonic fluid in order to correct volume depletion [44] . Recent data have revealed that all of these approaches result in hyponatremia [3,5 ,45,46] , with an almost 20% incidence of hospital-acquired hyponatremia (sodium <135 mEq/l) in children receiving hypotonic maintenance fluids following bolus therapy with 0.9% NaCl for gastroenteritis [5 ] . Children with volume depletion should receive 0.9% NaCl at a rate of 1500 ml/ m 2 per day, following initial bolus therapy. This not only serves as prophylaxis against hyponatremia, but will more rapidly expand the extracellular volume, correcting the volume depletion faster. If the child is assessed to have ongoing signs of volume depletion following the initial fluid bolus, it would be safer to give an additional fluid bolus rather than to increase the rate of IVF to greater than 1500 ml/m 2 per day. Once the child is deemed volume replete as evidenced by good urine output and peripheral perfusion, 0.9% NaCl could be discontinued in favor of hypotonic solutions or IVF discontinued altogether if oral intake is deemed adequate. It must be emphasized that patients with gastroenteritis with large ongoing gastrointestinal free water losses or high insensible losses from fever could develop hypernatremia from 0.9% NaCl. In these patients, and in patients with hypernatremic dehydration, 0.9% NaCl should only be used until the patient is deemed volume replete, after which hypotonic fluids should be used to keep up with ongoing losses and to treat hypernatremia (sodium >144 mEq/l). Close monitoring of serum sodium will be needed in these high-risk patients.
Euvolemic states of arginine vasopressin excess: syndrome of inappropriate secretion of antidiuretic hormone
There are many common childhood disorders that place hospitalized children at risk for developing hyponatremia due to nonosmotic and nonhemodynamic stimuli for AVP release, such as pneumonia [47] , bronchiolitis [48] , asthma [49] , positive pressure ventilation [50] , central nervous system (CNS) infections [51] , and head trauma [52] . Any euvolemic child who develops hyponatremia in the absence of renal insufficiency, congestive heart failure, nephrosis, cirrhosis, or adrenal insufficiency most likely has 'the syndrome of inappropriate secretion of antidiuretic hormone' (SIADH). SIADH is a disorder that can lead to hyponatremia due to the nonphysiologic secretion of ADH, which leads to free water retention followed by a natriuresis that maintains fluid balance at the expense of serum osmolality [53] . SIADH is one of the most common causes of hyponatremia in both children and adults in a hospital setting [54] . It has been reported in numerous conditions, but primarily occurs in children with central nervous system and pulmonary disorders and as a side effect of medications. Other common physiologic stimuli for AVP release that can lead to euvolemic hyponatremia indistinguishable from SIADH are nausea, vomiting, pain, stress, and hypoxia [55] . Virtually every hospitalized child should be considered at risk for the development of hyponatremia, and if IVF are needed 0.9% NaCl would be the most effective prophylaxis.
Postoperative setting
The need to administer IVFs is particularly important in the postoperative setting, as is the need to prevent hospital-acquired hyponatremia. Postoperative patients are at particular risk for developing both hospitalacquired hyponatremia and hyponatremic encephalopathy. The incidence of hospital-acquired hyponatremia is almost 30% in postoperative children [4 ] , and almost half of the reported cases of hyponatremic encephalopathy in children have occurred in postoperative children [8] , most of whom underwent minor surgical procedures [56] . Postoperative patients are at risk for developing euvolemic hyponatremia, which is similar to that seen with SIADH, due to numerous physiologic stimuli for AVP production, such as pain, stress, nausea, vomiting, narcotics, and volume depletion. Even a minor surgical procedure, such as a percutaneous renal biopsy, is associated with elevated AVP levels in 30% of patients [36 ] .
The main factor contributing to hyponatremia in the postoperative setting is the administration of hypotonic fluids. Many recent surveys and audits of fluid-prescribing practices reveal that hypotonic fluids are primarily being used in the postoperative setting [4 ,35,57-59] . We previously reported on 15 prospective studies conducted prior to 2003 in 500 adults and 50 children which revealed that isotonic fluids prevented postoperative falls in serum sodium and that hypotonic fluids, including Ringer's Lactate, resulted in falls in serum sodium [8] . Since that time, there have been six additional prospective studies in over 500 children that have revealed that isotonic fluids effectively prevent postoperative hyponatremia and that hypotonic fluids consistently result in declines in serum sodium (Table 3) [36 ,38,39 ,40 , 60] . In none of these studies was fluid overload or Intravenous fluid management for the acutely ill child Moritz and Ayus 189 Table 3 Prospective studies evaluating the relationship between intravenous fluid sodium concentration and change in serum sodium
Authors
Study design n Outcome Kanda et al. [36 ] Prospective observational study. Change in serum sodium at 5 h in children following a percutaneous renal biopsy receiving either 0.6% NaCl or 0.9% NaCl and with elevated AVP levels 60 Fall in SNa in 0.6% NaCl group of 1.9 mEq/l Increase in SNa in 0.9% NaCl group of 0.9 mEq/l Sumpelmann et al. [60] Prospective observation study. Change in intra-operative serum sodium in patient receiving a balanced electrolyte solution (Na 140 mEq/l) 107 Increase in SNa of 1 mEq/l Kannan et al. [37 ] Prospective randomized trial. Incidence of hyponatremia (SNa <130 mEq/l) within 72 h of initiated IVF in hospitalized children randomized to 0.18% NaCl at full or 2/3 maintenance and 0.9% NaCl at full maintenance 167 14.4% and 3.8% incidence of hyponatremia in 0.18% NaCl groups, respectively 1.7% incidence of hyponatremia with 0.9% NaCl group Neville et al. [39 ] Prospective randomized trial. Incidence of hyponatremia (Na <135 mEq/l) with 24 h in postoperative patients receiving either 0.45% or 0.9% NaCl at either full or 1/2 maintenance 124 29% and 32% incidence of hyponatremia in the 0.45% NaCl groups, respectively 3% and 16% incidence of hyponatremia in the 0.9% NaCl groups, respectively Yung and Keeley [40 ] Prospective randomized trial. Change in serum sodium at 12-24 h in children admitted to the ICU randomized to either 0.18% NaCl or 0.9% NaCl at 2/3 or full maintenance rate 50 Fall in SNa in 0.18% NaCl group by 3 mEq/l and 4.9 mEq/L, respectively Increase in SNa in the 0.9% NaCl group by 0.2 and 1.5 mEq/l, respectively. Montañ ana et al. [38] Prospective randomized trial. Incidence of hyponatremia (SNa <135 mEq/l) within 24 h in postoperative children admitted to the ICU receiving either hypotonic fluids (Na <100 mEq/l) or isotonic fluid (Na þ K ¼ 155 mEq/l) 122 20.6% incidence of hyponatremia in the hypotonic group 5.1% incidence of hyponatremia in the isotonic group significant hypernatremia a complication. It must be emphasized that Ringer's Lactate, sodium 130 mEq/l, can result in a fall in serum sodium. Ringer's Lactate is frequently used for intra-operative fluid management in children as it is a balanced solution with a physiologic amount of base, calcium and potassium, and will prevent a dilutional acidosis which can occur when large volumes of 0.9% NaCl are administered. A more suitably balanced solution to use intraoperatively would be Plasma-Lyte 148, sodium concentration 140 mEq/l, which has acetate as a base supplement.
Indications for fluid and sodium restriction
The administration of maintenance fluids at the rate of 1500 ml/m 2 /day with 0.9% NaCl is not appropriate for all disease states, and in some disorders it can result in serious fluid overload (Table 4 ). There are certain disease states where the ability to excrete both salt and water is severely impaired and both fluid and sodium restriction is necessary to prevent fluid overload. Disease states where both sodium and water restriction is indicated can be broadly classified as either edematous states or oliguric states. Below is a discussion of fluid management strategies in both conditions.
Edema-forming states
The most common conditions that lead to edema are congestive heart failure, hepatic cirrhosis, and nephrotic syndrome. The mechanism of edema formation and its treatment are different in each of these conditions. What they all have in common is an impaired ability to excrete free water due to decreased effective circulating volume, which makes hyponatremia a common associated complication.
In edema-forming states it is best to avoid IVF use altogether and manage the patient with oral sodium restriction and therapy directed to the underlying disease, including loop diuretics and albumin infusion when indicated. If IVFs are needed, fluid should be restricted to approximately 600 ml/m 2 per day, which would be equivalent to 1000 ml/day in an adult patient. Although it is unlikely that a hypotonic fluid, such as 0.45% sodium chloride (77 mEq/l), would result in a significant fall in serum sodium if the patient could be fluid restricted to this degree, many times patients are receiving significant amounts of unaccounted-for additional free water via intravenous medications, drips, or the oral route and hyponatremia could unexpectedly develop. Also, mild hyponatremia is a common finding in these patients and the administration of hypotonic fluids, even at a restricted rate, could perpetuate or aggravate the hyponatremia. Hyponatremia is an independent risk factor for mortality in both congestive heart failure and cirrhosis in adults, so in these patients fluid restriction with 0.9% NaCl may be the best choice. Patients receiving IVFs should have electrolytes measured at least daily along with daily weights and strict intake and output, and the IVF rate and composition should be adjusted accordingly to prevent fluid overload and dysnatremias.
Oliguric states
Oliguric acute kidney injury can result from decreased renal perfusion; ischemic, toxic, or obstructive insults; or glomerular or tubulointerstitial inflammatory processes. In prerenal states of acute kidney injury, such as sepsis or hypovolemic shock, fluid resuscitation is essential and life saving. An evolving literature suggests that fluid overload in children with hemodynamic instability and acute kidney injury is associated with increased mortality [61 ] . Excess fluid administration in children with oliguric acute kidney injury such as acute glomerulonephritis can result in complications such as congestive heart failure, pulmonary edema and severe hypertension. In these disease states fluid management must be carefully balanced between giving sufficient volume to reverse renal hypoperfusion and avoiding excess fluid overload and its resulting complications [62] . Fluid management in these patients is complicated and may include the use of diuretics and renal replacement therapies. In general a patient who is oligoanuric following the correction of any volume depletion should have his fluids restricted to approximately 400-600 ml/m 2 /day, which is roughly equal to insensible losses, unless he is receiving a renal replacement therapy or responding to diuretics. With this degree of fluid restriction it is unlikely that significant fluid overload or hyponatremia will develop, and a hypotonic fluid may be appropriate to replace insensible free water losses. Close monitoring of the patient's volume and electrolyte status will be needed and IVFs adjusted accordingly.
Indications for hypotonic fluid administration
Children with ongoing urinary or extra-renal free water losses will need to be provided with an adequate volume of electrolyte free water to prevent or correct hypernatremia and dehydration (Table 5 ). The administration of 0.9% NaCl could result in hypernatremic dehydration.
Renal concentrating defects
Children with renal concentration defects will usually need hypotonic fluids at a rate of administration equal to or greater than 1500 ml/m 2 per day. The composition and rate are largely determined by the severity of the renal concentrating defect. The most severe renal concentrating defects are seen with congenital nephrogenic diabetes insipidus, a rare hereditary disorder where there is varying resistance to AVP. These children can have severe polyuria and will typically require IVFs with approximately 0.1% NaCl at rates anywhere between 3000 and 6000 ml/m 2 per day to prevent or correct hypernatremia. If at all possible, their fluid needs are best met orally. A variety of conditions in children are associated with an acquired nephrogenic diabetes insipidus, where there may be only a partial concentrating defect. These children can be either asymptomatic or severely polyuric. If IVFs are required they should usually be hypotonic, but there are exceptions. In some forms of acquired nephrogenic diabetes insipidus, such as those due to a tubulopathy such as Bartter's syndrome or Fanconi syndrome, there is renal salt wasting that will require that fluids be administered at above-standard maintenance with significant sodium supplementation. Similarly, in polyuric states such as in the recovery phase of acute tubular necrosis, urinary electrolyte losses can be substantial and excessively hypotonic fluids could produce hyponatremia. In conditions of high-output chronic kidney disease, such as renal dysplasia, if the glomerular filtration rate (GFR) is greatly reduced there will be a relative inability to excrete free water, and the administration of excessive hypotonic fluids can also result in hyponatremia. In these disorders, the measurement of the urine sodium concentration can help aid in choosing the appropriate sodium concentration of IVF.
Patients with central diabetes insipidus (CDI) are best treated with Desmopressin (DDAVP). In patients with acute CNS injury, such as head trauma, the development of CDI can be abrupt, and severe hypernatremia can develop if they are receiving 0.9% NaCl. Urine output and serum sodium must be monitored closely in cases of acute CNS injury in order to detect central diabetes insipidus early and to administer hypotonic fluids until DDAVP is started. Once DDAVP is used, hypotonic fluids are no longer indicated and could result in dangerous hyponatremia.
Extra-renal free water losses
There are a variety of conditions where acutely ill, hospitalized children will have large extra-renal free water losses. The preterm neonate will have proportionally higher dermal insensible water losses than the older child and will need to be supplemented with free water. At the same time, preterm neonates have obligatory urinary sodium losses and reduced GFR, which puts them at risk for hyponatremia. Therefore, careful electrolyte monitoring is essential. Febrile patients will also have higher insensible losses, but if renal function is normal they should be able to generate free water by excreting a hypertonic urine and should not be at substantial risk for hypernatremia. Patients with large gastrointestinal free water losses from voluminous diarrhea, emesis, or intestinal drains are at risk for both hypernatremia and hyponatremia, depending on the composition of fluids they are receiving. Ongoing losses will need to be replaced with a composition of fluids that approximates gastrointestinal losses, usually 0.45% NaCl.
Conclusion
IVF therapy plays a critical role in the care of the acutely ill child. The administration of IVFs should be viewed as an invasive procedure, and the composition and rate of IVFs should be carefully adjusted as would be done with any other medication. The vast majority of hospitalized children requiring IVFs are at substantial risk for developing hospital-acquired hyponatremia, as they could have numerous stimuli for AVP production, including volume depletion, pain, stress, nausea, vomiting, respiratory and CNS disorders, and the postoperative state. There are numerous reports of death or permanent neurologic impairment from hospital-acquired hyponatremic encephalopathy in children receiving hypotonic fluids. There is an emerging literature that demonstrates that mild and asymptomatic hyponatremia may have adverse consequences. For the majority of patients an IVF sodium composition of 0.9% NaCl is the most physiologic, and numerous prospective studies have confirmed that it effectively prevents the development of hyponatremia. No single IVF rate or composition will be appropriate for all patients. Patients with edematous or oliguric states will need fluid and sodium restriction, and patients with ongoing urinary or extra-renal free water losses will need hypotonic fluids. Patients requiring IVF should have their volume status and electrolytes monitored regularly to assess the safety and efficacy of therapy.
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